RHI Magnesita Q1 FY27: consol PAT +83% YoY to ₹64.6 Cr, margin expands to 13.6%
PAT +83.19% YoY · revenue +5.59% · margins expanding · beat vs street
₹1,013.97 Cr
+5.59% YoY
₹64.61 Cr
+83.19% YoY
6.31%
+2.6pp YoY
₹3.13
RHI Magnesita India's consolidated revenue rose 5.6% YoY to ₹1,013.97 Cr (+8.8% QoQ) in Q1 FY27 (quarter ended June 30, 2026), while consolidated net profit jumped 83.2% YoY to ₹64.61 Cr from ₹35.27 Cr a year ago — both figures clean of one-off items on either side of the comparison, so the growth is organic. Standalone PAT grew a slower 68.0% YoY to ₹78.19 Cr on 7.2% revenue growth to ₹863.45 Cr; the wider consolidated gain implies the group's subsidiaries, including RHI Magnesita India Refractories Ltd (RHIMIRL, whose carrying value was written down at the standalone level last quarter), contributed disproportionately to the improvement — Intermetal Engineers and Ashwath Technologies alone added ₹6.78 Cr revenue and ₹1.03 Cr PAT to the consolidated numbers this quarter.
Q1 FY-2027 vs prior quarters
The operating margin (EBITDA excluding other income) expanded to roughly 13.6% of revenue from 10.65% a year ago, and net margin rose to 6.37% from 3.67%. Sequentially the quarter is a clean bounce-back from Q4 FY26's reported net loss, but that loss was entirely a function of the ~Rs.556 Cr consolidated goodwill impairment taken against RHIMIRL and is not a like-for-like base; on an adjusted basis Nuvama had pegged Q4 FY26 adjusted EBITDA margin at 12.1% (against its own estimate of a higher print), so this quarter's ~13.6% still marks genuine sequential margin improvement, consistent with price hikes flowing through.
The stock went into the print at ₹415.55, up 0.6% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records.
Management guides for Q4 margins to be similar to or slightly better than Q3's 13.7%, supported by a sustainable realization rate and a robust order book, though they remain cautious due to market headwinds. The long-term strategy focuses on expanding their high-value 4PRO solutions, which are expected to grow 4-5% nex
On the street side, no discrete Q1 FY27 PAT estimate was found, but Nuvama's post-Q4 note explicitly expected margin recovery in Q1 FY27 on price hikes and a robust order book, modelling 13%/13.5% EBITDA margins for FY27E/28E — the actual ~13.6% op margin already clears that full-year bar in the first quarter, a beat on trajectory even without a hard PAT comparison. Management gives no formal quarter-specific guidance on record for Q1 FY27 itself; the only prior guidance in our records (from the Q3 FY26 call) targeted Q4 FY26 margins near 13.7%, a bar that quarter missed on an adjusted basis (~12.1%), so this print is a partial recovery toward, not a return to, that earlier level. No press release commentary was available for this filing, so framing rests on the reported figures alone.
W1
Whether consolidated operating margin holds near/above the ~13% FY27E level Nuvama models, given price hikes are the stated driver
W2
Clarity on the incoming statutory auditor following Price Waterhouse's resignation effective August 14, 2026
W3
First financial contribution of the new RHI Khemka Minpro JV (51% stake) in coming quarters
Converted from Rs. Lakhs (source unit) to Rs. Crore by /100; both statement tables tie exactly to reported totals. Neither the current quarter nor the year-ago quarter carries an exceptional item, so raw and adjusted YoY growth are identical (no adjustment needed). The immediately prior quarter (Q4 FY26) carried a one-off goodwill/investment impairment (~Rs.556 Cr consolidated, ~Rs.661 Cr standalone) that pushed it to a net loss, so patQoQPct is left null as not meaningful.
Informational and educational content only. Not investment advice.